En ny væskebiopsi plattform

Offentlig prosjektsammendrag

GreinDX is developing a completely new device (GreinDisc) for cancer liquid biopsy analysis for use in medical research and clinical laboratories. The GreinDisc will enable high yield capturing and quick identification and characterization of circulating tumor cells (CTC). In addition, the GreinDisc will simultaneously capture circulating tumour DNA (ctDNA), circulating tumor proteins (ctPrt) and exosomes. The ability to profile a liquid biopsy in one go, for these 4 biomarker classes that tell-tale cancer, promises to transform the current landscape of cancer diagnostics, cancer prognosis and personalized cancer therapy. GreinDisc can be utilized for cancer liquid biopsies as well as for other rare cells applications as well as for organoid applications. The multifunctional capability of the GreinDisc is unique and represents a major innovation on a global scale.